ODTC Aaron I Davis buys $20.0M worth of shares
Jan 08, 2026, 11:36 AM
0.00%
What does ODTC do
Odonate, a San Diego-based pharmaceutical company, went public on December 7, 2017, and employs 137 full-time staff. It focused on developing tesetaxel, an investigational chemotherapy agent, but has discontinued its development.
Aaron I Davis bought 1,403,509 shares of ODTC on 28 August at $14.25 per share, worth a total of $20.0M. They now own 4,766,886 ODTC shares, or a 42% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.